Although the PIONEER and SUSTAIN studies only examined serious adverse reactions (SAEs) for people taking semaglutide, it is possible that similar reactions could occur after taking other GLP-1 drugs
The ADA/EASD consensus on glycaemic management algorithm already includes GLP-1 receptor agonists with cardiovascular benefit as an option for people with CKD when SGLT2 inhibitors are contraindicated or not tolerated, in order to reduce the risk of cardiovascular disease (Davies et al, 2022)
Once these trials are completed and regulatory reviews are finalised, the company may seek approval for global use
Detailed Mechanisms of Hormonal Regulation Glucagon-Like Peptide-1 (GLP-1) Function : GLP-1 is secreted in response to food intake, particularly carbohydrates and fats
For a closer look at the receptor science, see Retatrutide Triple Receptor Action
This becomes problematic because patients become dehydrated from not drinking, which harms kidney function